CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- 4 Planned sale Chief Customer Officer sold 3,635 shares at $140.00 ($508,900)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 15,000 shares at an average $123.25 ($1,848,795)
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 978 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 1,421 shares (to pay taxes)
- 4 Open-market sale Director sold 761 shares at $122.93 ($93,550)
- 4 Shares withheld for taxes EVP, General Counsel gave up 1,405 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,561 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,389 shares (to pay taxes)
- 4 Open-market sale Director sold 3,135 shares at $122.96 ($385,480)
- 4 Shares withheld for taxes EVP, General Counsel gave up 1,734 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 522 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 1,728 shares (to pay taxes)
- 4 Grant or award Director acquired 1,846 shares (grant or award)
- 4 Grant or award Director acquired 1,846 shares (grant or award)
- 4 Grant or award Director acquired 1,846 shares (grant or award)
- 4 Grant or award Director acquired 1,846 shares (grant or award)
- 4 Grant or award Director acquired 1,846 shares (grant or award)
- 4 Open-market sale Chief Tech Ops Officer sold 2,000 shares at an average $128.84 ($257,676)
- 4 Grant or award Director acquired 1,846 shares (grant or award)
Page 6 of 34 · 672 filings